Explore stories from Atlantic Canada.
Rick Mercer: Rants, Writings, and Road Trips | SaltWire #comedy #thinkingoutloud #ontour #canadian - A U.S. Senate committee said on Wednesday it had launched an investigation into the prices of Novo Nordisk's diabetes and weight loss drugs Ozempic and Wegovy in the United States.
Senator Bernie Sanders, chair of the Senate Committee on Health, Education, Labor and Pensions, sent a letter to Novo's CEO seeking more information on U.S. prices for the two drugs, which are higher than the prices in other countries.The committee also asked Novo if it will substantially reduce both the list price and the net price of both the drugs, and why the company was charging a higher price for the weight loss drug Wegovy than Ozempic, which contains the same compound.
"Novo Nordisk remains committed to working with policymakers to advance solutions to support access and affordability for all patients, and we reiterated this commitment in our conversation with Chairman Sanders," the company said in a statement to Reuters. Ozempic, approved for diabetes patients, and Wegovy belong to a class of drugs called GLP-1 agonists that reduces food cravings and causes the stomach to empty more slowly.ADVERTISEMENT
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US Senate committee investigates pricing of Novo's Ozempic and WegovyExplore stories from Atlantic Canada.
Read more »
No link between Ozempic, Wegovy and suicide, EU drug regulators sayDrug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal ...
Read more »
Novo’s Wegovy Aids Heart Failure Patients With Diabetes in StudyWegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, eased heart failure symptoms for patients with diabetes in the latest large trial to support use of the drug to treat health conditions linked to obesity.
Read more »
EU Probe Finds No Added Suicide Risk Linked to Novo’s WegovyThe European Union’s drug regulator found no added risk of suicide or self-harm for people taking a popular new class of weight-loss and diabetes medicines that includes Novo Nordisk A/S’s Wegovy and Ozempic.
Read more »
Bernie Sanders Wants to Meet Novo CEO Next Week on Ozempic PriceSenator Bernie Sanders wants to meet next week with Novo Nordisk A/S’s top executive about lowering the price of its blockbuster drug Ozempic, fueling controversy over the costs of GLP-1 drugs for diabetes and obesity.
Read more »
India's Biocon developing its own version of Wegovy, clinical trial likely next yearExplore stories from Atlantic Canada.
Read more »